Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024)

Seres Therapeutics' Interest Coverage Ratio history spans 5 years, with the latest figure at 46.66 for Q4 2024.

  • For Q4 2024, Interest Coverage Ratio changed N/A year-over-year to 46.66; the TTM value through Sep 2025 reached 167.36, up 147.2%, while the annual FY2023 figure was 79.05, 164.51% down from the prior year.
  • Interest Coverage Ratio for Q4 2024 was 46.66 at Seres Therapeutics, up from 55.72 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 91.94 in Q3 2021 and bottomed at 66.98 in Q4 2021.
  • The 5-year median for Interest Coverage Ratio is 34.23 (2022), against an average of 21.4.
  • The largest YoY upside for Interest Coverage Ratio was 323.77% in 2021 against a maximum downside of 184.05% in 2021.
  • A 5-year view of Interest Coverage Ratio shows it stood at 23.58 in 2020, then tumbled by 184.05% to 66.98 in 2021, then surged by 98.63% to 0.92 in 2022, then surged by 1915.67% to 16.72 in 2023, then soared by 179.11% to 46.66 in 2024.
  • Per Business Quant, the three most recent readings for MCRB's Interest Coverage Ratio are 46.66 (Q4 2024), 55.72 (Q1 2024), and 16.72 (Q3 2023).